Skeletal muscle mitoribosomal defects are linked to low bone mass caused by bone marrow inflammation in male mice. Issue 3 (20th March 2022)

• Record Type: Journal Article
• Authors: Tian, Jingwen; Chung, Hyo Kyun; Moon, Ji Sun; Nga, Ha Thi; Lee, Ho Yeop; Kim, Jung Tae; Chang, Joon Young; Kang, Seul Gi; Ryu, Dongryeol; Che, Xiangguo; Choi, Je‐Yong; Tsukasaki, Masayuki; Sasako, Takayoshi; Lee, Sang‐Hee; Shong, Minho; Yi, Hyon‐Seung
• Is Part Of: Journal of cachexia, sarcopenia and muscle. Volume 13:Issue 3(2022)
• Page Start: 1785
• Page End: 1799
• Publication Date: 2022-03-20
• Subjects: Mitochondria -- Inflammation -- Bone marrow -- Bone loss; Cachexia -- Periodicals; Muscles -- Aging -- Periodicals; Muscles -- Periodicals; Cachexia; Sarcopenia; Muscles; Cachexia; Muscles; Muscles -- Aging; Periodicals; Periodicals; 616
• DOI: 10.1002/jcsm.12975
• Languages: English
• ISSNs: 2190-5991

Abstract

Abstract: Background: Mitochondrial oxidative phosphorylation (OxPhos) is a critical regulator of skeletal muscle mass and function. Although muscle atrophy due to mitochondrial dysfunction is closely associated with bone loss, the biological characteristics of the relationship between muscle and bone remain obscure. We showed that muscle atrophy caused by skeletal muscle‐specific CR6‐interacting factor 1 knockout (MKO) modulates the bone marrow (BM) inflammatory response, leading to low bone mass. Methods: MKO mice with lower muscle OxPhos were fed a normal chow or high‐fat diet and then evaluated for muscle mass and function, and bone mineral density. Immunophenotyping of BM immune cells was also performed. BM transcriptomic analysis was used to identify key factors regulating bone mass in MKO mice. To determine the effects of BM‐derived CXCL12 (C–X–C motif chemokine ligand 12) on regulation of bone homeostasis, a variety of BM niche‐resident cells were treated with recombinant CXCL12. Vastus lateralis muscle and BM immune cell samples from 14 patients with hip fracture were investigated to examine the association between muscle function and BM inflammation. Results: MKO mice exhibited significant reductions in both muscle mass and expression of OxPhos subunits but increased transcription of mitochondrial stress response‐related genes in the extensor digitorum longus ( P < 0.01). MKO mice showed a decline in grip strength and a higher drop rate in the wire hanging test ( P < 0.01). Micro‐computed tomography and von Kossa staining revealed that MKO mice developed a low mass phenotype in cortical and trabecular bone ( P < 0.01). Transcriptomic analysis of the BM revealed that mitochondrial stress responses in skeletal muscles induce an inflammatory response and adipogenesis in the BM and that the CXCL12–CXCR4 (C–X–C chemokine receptor 4) axis is important for T‐cell homing to the BM. Antagonism of CXCR4 attenuated BM inflammation and increased bone mass in MKO mice. In humans, patients with low body mass index (BMI = 17.2 ± 0.42 kg/m 2 ) harboured a larger population of proinflammatory and cytotoxic senescent T‐cells in the BMI ( P < 0.05) and showed reduced expression of OxPhos subunits in the vastus lateralis, compared with controls with a normal BMI (23.7 ± 0.88 kg/m 2 ) ( P < 0.01). Conclusions: Defects in muscle mitochondrial OxPhos promote BM inflammation in mice, leading to decreased bone mass. Muscle mitochondrial dysfunction is linked to BM inflammatory cytokine secretion via the CXCL12–CXCR4 signalling axis, which is critical for inducing low bone mass.